Of the 128 lead PSA variants, 52 (41%) were associated with prostate cancer at the Bonferroni-corrected threshold (P < 0.05/128) in the PRACTICAL consortium’s European ancestry GWAS32 (Supplementary Table 8). Here, KLK3 is linked to prostate carcinoma.